Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 28;5(1):80-85.
doi: 10.1136/svn-2019-000262. eCollection 2020.

Acute ischaemic stroke interventions: large vessel occlusion and beyond

Affiliations
Review

Acute ischaemic stroke interventions: large vessel occlusion and beyond

Ahmad Sweid et al. Stroke Vasc Neurol. .

Abstract

Care for acute ischaemic stroke is one of the most rapidly evolving fields due to the robust outcomes achieved by mechanical thrombectomy. Large vessel occlusion (LVO) accounts for up to 38% of acute ischaemic stroke and comes with devastating outcomes for patients, families and society in the pre-intervention era. A paradigm shift and a breakthrough brought mechanical thrombectomy back into the spotlight for acute ischaemic stroke; this was because five randomised controlled trials from several countries concluded that mechanical thrombectomy for acute stroke offered overwhelming benefits. This review article will present a comprehensive overview of LVO management, techniques and devices used, and the future of stroke therapy. In addition, we review our institution experience of mechanical thrombectomy for posterior and distal circulation occlusion.

Keywords: functional outcome; large vessel occlusion; mechanical thrombectomy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: PJ is a consultant for Medtronic and Micro Vention. ST is a consultant for Stryker.

Similar articles

Cited by

References

    1. Hopkins LN, Beumer D, Mulder M. Blazing the frontiers of stroke therapy. Neurosurgery 2019;85:S1–2. 10.1093/neuros/nyz004 - DOI - PubMed
    1. Adeoye O, Hornung R, Khatri P, et al. . Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 2011;42:1952–5. 10.1161/STROKEAHA.110.612358 - DOI - PMC - PubMed
    1. Saqqur M, Uchino K, Demchuk AM, et al. . Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948–54. 10.1161/01.STR.0000257304.21967.ba - DOI - PubMed
    1. De Silva DA, Brekenfeld C, Ebinger M, et al. . The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2010;41:295–9. 10.1161/STROKEAHA.109.562827 - DOI - PubMed
    1. Paciaroni M, Balucani C, Agnelli G, et al. . Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion. Stroke 2012;43:125–30. 10.1161/STROKEAHA.111.630624 - DOI - PubMed

MeSH terms